Clinical Trial Update: A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

AstraZeneca reports a Phase 1 clinical trial of AZD0486 in B-cell non-Hodgkin lymphomas, including diffuse large B-cell lymphoma, high-grade B-cell lymphoma, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• AZD0486 (AZD0486)

Snippet

Sponsor: AstraZeneca | Conditions: B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | Status: RECRUITING